Clarus Therapeutics Holdings Inc

NASDAQ:CRXT   1:54:27 PM EDT
0.40
+0.02 (+4.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)20.66M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.97 Million
Adjusted EPS-$0.29
See more estimates
10-Day MA$0.43
50-Day MA$0.98
200-Day MAN/A
See more pivots

Clarus Therapeutics Holdings Inc Stock, NASDAQ:CRXT

555 Skokie Boulevard, Suite 340, Northbrook, Illinois 60062
United States of America
Phone: +1.847.562.4300
Number of Employees:

Description

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Northbrook, IL.